Role of cytochrome c as a novel signaling molecule by the investigation of LRG knock-out mouse
Project/Area Number |
23590096
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Biological pharmacy
|
Research Institution | Osaka University of Pharmaceutical Sciences |
Principal Investigator |
INOUE Seiji 大阪薬科大学, 薬学部, 准教授 (70183184)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 生体分子 / 蛋白質 / 生理活性 |
Research Abstract |
Leucine-rich alpha2-glycoprotein (LRG), one of the serum proteins with unknown function, was found to bind tightly and form complex with the extracellular cytochrome c (Cytc). The positive charges of the residues 8, 13, 72, 73, and 79 of Cytc molecule were important to this binding. A Cytc-LRG complex would function as a danger signal that modulates the immune cells such as bone marrow-derived macrophages to induce G-CSF expression, leading to the neutrophil proliferation in bone marrow.
|
Report
(4 results)
Research Products
(7 results)